NAOS Small Cap Opportunities Company Limited Overview
| Field | Input list (supplied) | Verified current position | Note |
|---|---|---|---|
| Legal name | NAOS Small Cap Opportunities Company Limited | NAOS Small Cap Opportunities Company Limited | Confirmed [AR26] |
| Country | Australia | Australia (registered and domiciled) | Confirmed [AR26] |
| Exchange | Australian Securities Exchange | ASX | Confirmed |
| Ticker | NSC.AX | ASX: NSC (Yahoo-style: NSC.AX) | Confirmed |
| ISIN | JP3670800006 | AU000000NSC4 [AGG – TradingView] | The input ISIN is wrong. The "JP" prefix denotes a Japanese security. The Australian ISIN is AU000000NSC4. |
| Website | contango.com.au/.../contango-microcap-limited/ | www.naos.com.au | The input URL is obsolete. It refers to the pre-2017 manager (Contango) and the former name (Contango MicroCap Limited). |
Entity profiled: NAOS Small Cap Opportunities Company Limited (ACN 107 617 381; ABN 47 107 617 381). It is listed on the ASX under ticker NSC, and its website is naos.com.au. It is the same legal entity formerly named Contango MicroCap Limited (ASX: CTN).
Snapshot table
| Item | Detail | Source |
|---|---|---|
| Legal name | NAOS Small Cap Opportunities Company Limited | [AR26] |
| Former name | Contango MicroCap Limited (ASX: CTN) | [AGG] |
| Founded / constituted | Constituted 14 January 2004; commenced operations 25 March 2004 | [AR26] Notes |
| Listing date | Not confirmed from primary filings. TradingView gives an IPO date of 28 Jan 2004, which conflicts with the operations start date of 25 Mar 2004 in [AR26]. Treat as early 2004. | [AGG] vs [AR26] |
| Incorporation jurisdiction | Australia (public company under the Corporations Act 2001) | [AR26] |
| Registered office / HQ | Level 34, 25 Martin Place, Sydney NSW 2000 | [AR26] |
| Exchange / ticker | ASX: NSC | [AR26] |
| Other listed securities | None currently. Unlisted wholesale notes are on issue (face value $13,243,000). Formerly listed: Contango Convertible Notes (ASX: NSCG), redeemed Dec 2019. | [NTA-Jul26]; ASX 28 Nov 2019 |
| ISIN | AU000000NSC4 | [AGG] |
| CUSIP | Not applicable / not publicly disclosed | — |
| Fiscal year end | 30 June | [AR26] |
| Employees | Nil. The Company has no executive employees; investment management, administration and company secretarial functions are outsourced to the Investment Manager. | [AR26] Remuneration Report |
| Employee trend (3 years) | FY24: 0; FY25: 0; FY26: 0 | [AR26] |
| Investment Manager | NAOS Asset Management Pty Ltd (ACN 107 624 126; AFSL 273529). Renamed from NAOS Asset Management Limited effective 7 Aug 2026. Appointed 20 Oct 2017. | [AR26] |
| Auditor | Deloitte Touche Tohmatsu (lead partner: Jonathon Corbett) | [AR26] |
| Shares on issue | 132,001,294 (30 Jun 2026 and 31 Jul 2026) | [AR26]; [NTA-Jul26] |
| Market capitalisation | ~$41.6m at 31 Jul 2026 ($0.315/share); ~$42m at ~$0.32/share in recent trading | [NTA-Jul26]; [AGG – InvestSMART] |
| Pre-tax NTA per share | $0.2809 (30 Jun 2026); $0.28 (31 Jul 2026) | [AR26]; [NTA-Jul26] |
| Post-tax NTA per share | $0.37 (30 Jun 2026); $0.41 (31 Jul 2026) | [AR26]; [NTA-Jul26] |
| Benchmark | S&P/ASX Small Ordinaries Accumulation Index (XSOAI) | [AR26] |
| Fees | Management fee 1.15% p.a.; performance fee 20% of outperformance, with prior under-performance to be recouped | [NTA-Jul26] |
NSC is a small (~$42m market capitalisation, ~$50m gross portfolio) closed-ended LIC. It provides concentrated, long-horizon exposure to Australian and New Zealand emerging industrial companies and excludes resources. It is managed by NAOS Asset Management, a Sydney boutique that is majority-owned by its staff and directors, and it sits between the NAOS Emerging Opportunities (NCC) and NAOS Ex-50 (NAC) strategies by investee size. The portfolio holds only eight positions, has a weighted average investee market cap of ~$116m, and has a weighted holding period of ~70 months. Fewer than 1% of its holdings by weight are benchmark constituents. The vehicle's shareholder proposition rests on a high quarterly dividend (5.0 cps p.a., partially franked) and an active buyback. Since NAOS took over in December 2017, the investment portfolio has materially underperformed its benchmark: -3.27% p.a. versus +5.65% p.a. to 30 June 2026. The vehicle also carries meaningful note-funded leverage against a shrinking asset base.
Company's own description (paraphrased from [AR26])
NSC states that its objective has three parts:
-
provide long-term concentrated exposure to Australian and New Zealand emerging companies;
-
deliver a sustainable stream of dividends franked to the maximum extent possible;
-
achieve long-term performance above the S&P/ASX Small Ordinaries Accumulation Index.
The Directors' Report describes the principal activity as investing primarily in a concentrated portfolio of listed equities, excluding resource companies. The monthly update adds that NSC's investees are generally slightly larger than those held by sister LIC NCC [NTA-Jul26].
Business model
| Dimension | Characterisation |
|---|---|
| Legal / economic form | Closed-ended, ASX-listed investment company. Capital is permanent (no redemption risk), and shareholders exit by selling on-market. |
| Revenue model | No product, service, subscription or licensing revenue. "Revenue" is investment income: dividends, interest, and realised plus unrealised gains/losses on financial assets at fair value through profit or loss. It can be, and in FY24–FY26 was, negative. |
| Cost model | External management fee (1.15% p.a.), potential performance fee (20%), interest on unsecured notes, transaction costs, listing/registry/custody, audit/legal, and directors' fees. |
| Funding model | Equity (132.0m shares) plus $13.24m face value of unlisted unsecured wholesale notes [NTA-Jul26]. |
| Shareholder return levers | (1) Portfolio return; (2) quarterly dividends paid from a profits reserve; (3) on-market buybacks at a discount to NTA; (4) DRP satisfied on-market to avoid dilution. |
| Value-chain position | Capital allocator and engaged minority shareholder in small industrial companies, sometimes with board representation or influence over board appointments ([AR26] "Investing with NAOS"). |
| Customer types | Shareholders (predominantly retail/SMSF investors in NAOS's ~5,500-investor base across its vehicles) and wholesale noteholders. |
| End-markets (indirect, via investees) | Building products distribution (BRI), medical devices / sleep apnoea (SOM), truck and trailer parts (MXI), NZ freight and logistics (MOV), school uniforms and sportswear (SBZ), engineering and construction for the water, defence and fuel sectors (SND). |
Independent characterisation
NSC is effectively a leveraged, eight-stock, deep-value/turnaround small-cap portfolio. Its outcomes depend on a handful of illiquid micro- and small-caps.
Three features dominate its economics:
Extreme concentration: Eight holdings. Single-name events can move NAV 20–30% in a month: February 2025 was -30.14% after BSA lost its NBN Co contract [NTA-Jul26]; [AGM25].
Structural leverage: Notes of $13.24m sit against a ~$50m portfolio, roughly 26% gross gearing. They equal ~36% of pre-tax NAV of ~$37.1m (132.0m shares × $0.2809).
A dividend policy that exceeds earnings: The 5.0 cps annual dividend equals ~18% of the 30 Jun 2026 pre-tax NTA. It is funded from a profits reserve (7.9 cps at 30 Jun 2026) rather than from recurring income.
Shareholder returns have therefore diverged sharply from portfolio returns. FY26 total shareholder return was +33.14% while the portfolio returned -9.86%, because the share price moved from a 26.64% discount to a 15.70% premium to pre-tax NTA [AR26].
Strategy
Stated strategy (themes from [AR26], paraphrased)
Concentration: Zero to twenty holdings ("quality over quantity").
Long-term perspective: Many core investments are held for three or more years.
Management alignment: Back proven, owner-aligned management teams.
Ignore the index: More than 90% of the portfolio sits outside ASX indices.
Circle of competence: Avoid businesses dominated by interest rates or commodity prices.
Liquidity premium: Exploit the illiquidity of small caps, enabled by the closed-end structure.
Constructive engagement: Contribute growth capital, help on capital management and strategy, and on occasion take board seats.
ESG integration and negative screens: Excludes tobacco, gambling, nuclear/uranium, controversial weapons, coal mining, oil and gas production, and animal cruelty.
The investment universe funnel runs from 2,203 ASX-listed companies to 312 in the NAOS universe, to 41–90 on the active watchlist, to 0–20 holdings [AR26].
Initiatives in the last 24 months
| Initiative | Date | Detail | Status |
|---|---|---|---|
| Debt refinancing and deleveraging | FY25 | $32.17m of notes repaid; $13.11m new notes issued | Completed |
| Ongoing buyback | FY25–FY26 | 2.07m shares (FY25) and 0.91m shares (FY26) cancelled; buyback notifications dated 17 and 22 Apr 2026 | Ongoing |
| Non-dilutive DRP | Ongoing | DRP satisfied on-market while shares trade at a discount | Ongoing |
| Quarterly dividend maintenance | FY25–FY26 | 1.25 cps per quarter maintained despite losses; franking reduced | Ongoing |
| Shareholder engagement | Ongoing | Quarterly webinars, quarterly reports, monthly NTA, roadshows (Oct–Nov 2026) | Ongoing |
| Manager restructure | 7 Aug 2026 | NAOS Asset Management Limited became a Pty Ltd | Completed |
| Portfolio repositioning | FY26 | SomnoMed added as a newer core holding (featured in the Q3 FY26 report) | Completed |
Medium-term targets and guidance
NSC gives no financial guidance. The Board anticipates "a significantly stronger FY27", citing positive post-year-end updates from holdings [AR26]. The manager identified FY27 catalysts at MOV, BRI, SOM and SND (see §22). There are no quantified NAV, return or dividend targets beyond the dividend objective.
Products & Services
As an LIC, NSC's "products" are (a) its own listed shares and associated shareholder programs, and (b) its investment portfolio. Both are catalogued below.
Securities and shareholder programs
| Offering | Description | Target holder | Latest status | Pricing / terms |
|---|---|---|---|---|
| NSC ordinary shares | ASX-listed exposure to the concentrated portfolio | Retail, SMSF, advised investors | 132,001,294 on issue | Market price ~$0.32 |
| Quarterly dividends | 1.25 cps per quarter (5.0 cps p.a.) | All shareholders | Maintained through FY26; FY26 dividends 50% franked | Funded from profits reserve (7.9 cps at 30 Jun 2026) |
| Dividend Reinvestment Plan (DRP) | Reinvest dividends without brokerage; satisfied on-market when shares trade below NTA | Shareholders | Active; FY26 DRP $914k all bought on-market | No discount disclosed |
| On-market buyback | Accretive purchases below NTA | — | FY26: 906,890 shares for $290,893; notices dated 17 Apr 2026 and 22 Apr 2026 | Discretionary |
| Unlisted unsecured notes | Wholesale debt funding | Wholesale investors | Face value $13,243,000 | implied cash cost ~8.6% (FY26 cash interest $1.142m ÷ $13.24m) |
Investment portfolio, holding by holding (30 Jun / 31 Jul 2026)
| Holding | Ticker | Description (as disclosed by NAOS) | Key datapoints | NAOS thesis / catalysts | Source |
|---|---|---|---|---|---|
| Big River Industries | ASX: BRI | Manufacturer and distributor of value-added timber and building materials in Australia and NZ | 25 sites; >9,000 trading accounts; ~570 staff; ~65% residential exposure; revenue ~$500m | Dec 2025 acquisition of Johns Building Supplies (WA) for $17m; CTL (Aust) built a ~19.9% stake; strategic review with Greenstone Partners; FY27 guidance of double-digit EBITDA growth | [AR26] |
| SomnoMed | ASX: SOM | Global leader in oral appliances for obstructive sleep apnoea, operating in 28 countries; >1m devices delivered since 2004 | FY25 revenue ~$112m; FY26 preliminary revenue $114–115m (below $119–126m guidance); EBITDA mid-range of $10–12m guidance; ~61% gross margin; Philippines manufacturing | Margin expansion via automation; market share gains; Rest Assure sensor-enabled device (FDA clearance for compliance monitoring; efficacy approval pending); new Virtus product | [AR26] |
| MaxiPARTS | ASX: MXI | Commercial truck and trailer aftermarket parts | >162,000 parts; 30 sites; >30 years in operation | Not detailed in AR26 | [AR26]; [NTA-Jul26] |
| MOVe Logistics Group | ASX/NZX: MOV | One of NZ's largest freight and logistics providers | >750 staff; >3,500 customers; 40 branches; revenue ~NZ$300m; market cap ~NZ$25m | Return to positive normalised EBT in FY26 (confirmed July 2026); exit of onerous warehousing leases; target 3–5% NPAT margin | [AR26] |
| Schoolblazer Ltd | ASX: SBZ | Global schoolwear and sportswear platform (Schoolblazer UK, Trutex, Mountcastle) | Renamed Feb 2026; ~1,000 contracted schools; ~A$200m FY27 revenue target; board and executives own ~25% | E-commerce expansion (MySchool.Shop); sourcing and technology integration | [AR26] |
| Saunders International | ASX: SND | Engineering and construction (core plus water and defence expansion) | Returned to profit in 2H FY26 under a new CEO | Larger water and defence contracts; data centre and defence tailwinds | [AR26] |
| BSA Limited (status unclear) | ASX: BSA | Telco and infrastructure services | Lost NBN Co tender Feb 2025; share price fell ~90% | Whether still held is not disclosed | [AGM25] |
| Two further holdings | — | — | — | — | — |
The portfolio has eight holdings, a 0.50% cash weighting, a weighted average investee market cap of $116.4m, and a weighted holding period of 70 months [NTA-Jul26]. Individual position weights are not publicly disclosed. The six named holdings are below; the remaining two are not publicly disclosed.
Sister strategies managed by NAOS (context, not NSC products)
| Vehicle | Mandate | Benchmark | Source |
|---|---|---|---|
| NAOS Emerging Opportunities (ASX: NCC) | Smaller emerging companies; NAOS's first LIC, 2013 | S&P/ASX Small Ordinaries Accumulation | [Q4FY26] |
| NAOS Ex-50 Opportunities (ASX: NAC) | Industrials outside the ASX 50 | S&P/ASX 300 Industrials Accumulation | [Q4FY26] |
| NAOS Private Opportunities Fund | Wholesale private/public | — | [AR26] |
Financial Narrative
Data provenance. FY25–FY26 line items come from audited statements in [AR26]. FY22–FY26 net result, equity, post-tax NTA and share price come from the audited 5-year table in [AR26]. FY22–FY24 income and operating cash flow come from [AGG] and should be treated as indicative.
Income statement
Expense discipline. Total operating expenses fell 20% (3,905k to 3,133k). Interest fell 22% after the FY25 debt paydown, and management fees fell 24% as assets shrank. The management expense ratio rose from 2.1% (FY23) to 2.4% (FY24) to 3.5% (FY25) [AGG – InvestSMART], because fixed costs were spread over a shrinking base.
Balance sheet
Notes
-
FY24 borrowings of 32,171k are inferred from the FY25 note repayment of $32.171m, an analyst inference. Contemporaneous disclosures show the 2019 issue at $27m, so the 32,171k likely includes later top-ups.
-
InvestSMART reports FY24 equity of $95.9m and FY23 equity of $135.7m, which conflicts with the audited 5-year table ($79.2m and $112.2m). The audited [AR26] figures are used.
-
The DTA of $12.2m equals ~9.2 cps. This is why post-tax NTA ($0.37) exceeds pre-tax NTA ($0.28). The value of post-tax NTA therefore depends on future taxable profits being generated to use the tax losses.
Cash flow
Notes. FY22–FY24 operating cash flow is from [AGG]. For an LIC, operating cash flow includes net investment sales and purchases, so it reflects portfolio realisation rather than recurring earnings. Recurring cash yield is thin. In FY26, dividends received ($1.78m) did not cover interest paid ($1.14m) plus other cash costs ($1.31m), let alone $6.6m of dividends. The shortfall was met by net portfolio sales of $7.7m.
Ratios
Notes
-
Payout ratios for FY23–FY25 are from [AGG].
-
For FY2025, notes face value to gross portfolio uses the carrying value of $12.7m against $63.6m.
-
ROIC, net debt/EBITDA, asset turnover and cash conversion cycle are not meaningful for an LIC with negative EBITDA and no working-capital cycle.
Trend commentary
-
Capital base erosion. Equity fell from $120.4m (FY22) to $49.2m (FY26), a 59% decline. The causes are cumulative losses of ~$57m over FY22–FY26 (–19.8, +2.6, –24.3, –9.1, –6.6) plus ~$33m of dividends paid out at 5 cps p.a. Post-tax NTA per share fell 56%, from $0.84 to $0.37.
-
Inflection that did not hold. The portfolio rebounded ~+24% from March to June 2025 [AGM25] and +9.69% in H1 FY26 [HY26], suggesting a recovery. Each month from February to June 2026 was then negative. The board attributed this to "share price reductions in a small number of large holdings" against a backdrop of RBA rate increases (+0.75% to 4.35%) and higher oil prices [AR26].
-
Deleveraging, then re-gearing by attrition. The FY25 refinancing cut debt by ~$19m. Because assets kept shrinking, notes as a share of the portfolio rose again, from ~20% to ~26.5%.
-
Dividend sustainability. The profits reserve stood at 7.9 cps against a 5.0 cps annual payout, about 1.6 years of cover without new realised profits. Franking fell from 100% (FY22–FY24) to 50% on FY26 declarations, signalling depleted franking credits.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Income Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total investment income (AUD K) | -27,343 | 3,410 | -30,063 | -5,634 | -3,567 |
Management fees (AUD K) | — | — | — | 957 | 732 |
Performance fees (AUD K) | — | — | — | 0 | 0 |
Interest expense (AUD K) | — | — | — | 1,495 | 1,172 |
Transaction costs (AUD K) | — | — | — | 468 | 371 |
Listing custody registry fees (AUD K) | — | — | — | 233 | 175 |
Legal and professional fees (AUD K) | — | — | — | 71 | 91 |
Amortisation (AUD K) | — | — | — | 153 | 113 |
Directors remuneration (AUD K) | 85 | 106 | 110 | 110 | 110 |
Other expenses (AUD K) | — | — | — | 418 | 369 |
Total expenses (AUD K) | — | — | — | 3,905 | 3,133 |
Pre-tax result (AUD K) | — | — | — | -9,539 | -6,700 |
Income tax benefit (AUD K) | — | — | — | 468 | 103 |
Net profit after tax (AUD K) | -19,788 | 2,610 | -24,282 | -9,071 | -6,597 |
EBITDA proxy pre-tax plus interest plus amortisation (AUD K) | — | — | — | -7,891 | -5,415 |
EPS basic and diluted (AUD cents) | — | 1.9 | -17.9 | -6.74 | -5.00 |
Dividends declared per share (AUD cents) | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
Franking of dividends paid in year (%) | 100 | 100 | 100 | 75 | 37.5 |
Balance Sheet and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Financial assets at fair value (AUD K) | — | — | — | 63,611 | 50,033 |
Cash and equivalents (AUD K) | — | — | 360 | 203 | 305 |
Deferred tax asset (AUD K) | — | — | — | 12,000 | 12,169 |
Total assets (AUD K) | — | — | — | 75,945 | 62,697 |
Borrowings unsecured notes carrying value (AUD K) | — | — | 32,171 | 12,748 | 12,861 |
Short-term debt (AUD K) | — | — | — | 0 | 0 |
Net debt (AUD K) | — | — | 31,811 | 12,545 | 12,556 |
Total liabilities (AUD K) | — | — | — | 13,211 | 13,456 |
Shareholders equity (AUD K) | 120,401 | 112,203 | 79,159 | 62,734 | 49,241 |
Profits reserve (AUD K) | — | — | 16,765 | 10,025 | 10,405 |
Goodwill and intangibles (AUD K) | 0 | 0 | 0 | 0 | 0 |
Working capital (AUD K) | — | — | — | 63,482 | 49,933 |
Post-tax NTA per share (AUD) | 0.84 | 0.81 | 0.59 | 0.47 | 0.37 |
Pre-tax NTA per share (AUD) | — | — | 0.50 | 0.3817 | 0.2809 |
Dividends & Capital Returns
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Net operating cash flow (AUD K) | 10,948 | 10,668 | 8,803 | 26,694 | 6,998 |
Purchases of investments (AUD K) | — | — | — | 33,956 | 42,849 |
Proceeds from sale of investments (AUD K) | — | — | — | 61,100 | 50,582 |
Dividends received (AUD K) | — | — | — | 2,627 | 1,781 |
Interest paid to noteholders (AUD K) | — | — | — | 1,408 | 1,142 |
Capex (AUD K) | 0 | 0 | 0 | 0 | 0 |
Free cash flow (AUD K) | 10,948 | 10,668 | 8,803 | 26,694 | 6,998 |
Dividends paid in cash net of DRP (AUD K) | — | — | — | 5,742 | 5,691 |
DRP shares bought on-market (AUD K) | — | — | — | 998 | 914 |
Share buybacks (AUD K) | — | — | — | 614 | 291 |
Notes repaid (AUD K) | — | — | — | 32,171 | 0 |
Notes issued (AUD K) | — | — | — | 13,110 | 0 |
Margin Analysis (%) and Financial Ratios (x)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE on average equity (%) | -16.4 | 2.2 | -25.4 | -12.8 | -11.8 |
ROA on closing assets (%) | — | — | — | -11.9 | -10.5 |
Current ratio (x) | — | — | — | 138.1 | 84.9 |
Debt to equity (%) | — | — | 40.6 | 20.3 | 26.1 |
Notes face value to gross portfolio (%) | — | — | — | 20.0 | 26.5 |
Interest coverage pre-tax plus interest over interest (x) | — | — | — | -5.4 | -4.7 |
Dividend payout of NPAT (%) | — | 269 | -28 | -74 | -100 |
Investment portfolio return (%) | -14.72 | 2.62 | -22.93 | -9.08 | -9.86 |
Benchmark XSOAI return (%) | — | — | — | 12.26 | 8.11 |
Results by Region
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Australia and NZ investment income (AUD K) | -30,063 | -5,634 | -3,567 |
Share Price and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Share price at 30 June (AUD) | 0.73 | 0.68 | 0.44 | 0.28 | 0.325 |
Post-tax NTA per share (AUD) | 0.84 | 0.81 | 0.59 | 0.47 | 0.37 |
Price to post-tax NTA (x) | 0.87 | 0.84 | 0.75 | 0.60 | 0.88 |
Price to pre-tax NTA (x) | — | — | 0.88 | 0.73 | 1.16 |
Dividend per share (AUD cents) | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
Dividend yield at year-end price (%) | 6.8 | 7.4 | 11.4 | 17.9 | 15.4 |
Market capitalisation (AUD Mn) | — | 93.8 | 59.4 | 37.2 | 42.9 |
Share buyback (AUD K) | — | — | — | 614 | 291 |
Change by Period
| Period | Change | Basis |
|---|---|---|
1 year (to 31 Jul 2026) | ~+8.6% (price only) | [AGG – Investing.com] |
FY26 total shareholder return | +33.14% (+35.41% including franking) | [AR26] |
3 years (30 Jun 2023 to 30 Jun 2026) | -52.2% (price only; 0.68 to 0.325) | Calculated from [AR26] |
4 years (30 Jun 2022 to 30 Jun 2026) | -55.5% (price only) | Calculated from [AR26] |
52-week range | $0.285–$0.45 | [AGG – Investing.com, Jul 2026] |
Recent price | ~$0.32 | [AGG – InvestSMART] |
Valuation Snapshot
| Multiple | Value | Comment |
|---|---|---|
Market cap | ~$42.2m | 132.0m × $0.32 |
Enterprise value | ~$55.1m | Plus $13.24m notes less ~$0.3m cash |
Price / pre-tax NTA (Jul 2026) | ~1.14x (~14% premium) | Unusual for a sub-scale LIC |
Price / post-tax NTA (Jul 2026: $0.41) | ~0.78x | Flattered by the DTA |
Trailing dividend yield | ~15.6% (unfranked basis) | 5 cps / 32c |
P/E, EV/EBITDA, EV/Sales | Not meaningful (negative earnings and revenue) | — |
Analyst consensus | None. No broker coverage identified. | — |
Credit ratings (Moody's / S&P / Fitch) | Not rated. The 2019 notes were explicitly unrated; the current notes are presumed unrated. | ASX 2019 |
Per-Share Data
| Metric | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|
Dividends declared (AUD cents) | 5.50 | 4.00 | 4.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
Capital Instruments
| Instrument | Face value | Coupon | Maturity | Status |
|---|---|---|---|---|
Contango Convertible Notes (NSCG) | $26.5m | — | 31 Mar 2020 | Redeemed ~17 Dec 2019 |
Unlisted wholesale notes (2019) | $27m (repaid balance $32.17m in FY25) | 4.95% p.a., subject to step-up | 3 Dec 2024 | Repaid FY25 |
Unlisted unsecured notes (current) | $13,243,000 | — | — | Outstanding; non-current at 30 Jun 2026, so the maturity is after Jun 2027 |
Analyst Conclusions
Management guidance
-
No quantitative guidance is given. The Board expects "a significantly stronger FY27" [AR26], citing post-balance-date updates from investees.
-
The manager named four FY27 catalysts:
-
MOV moving to sustainable profitability (3–5% NPAT margin target);
-
BRI delivering a step-change in earnings, plus M&A optionality (JBS acquisition, CTL stake, strategic review);
-
SomnoMed expanding margins and progressing Rest Assure (commercial clarity expected by end CY26);
-
SND winning larger water and defence contracts.
-
-
There are no consensus forecasts.
Bull case
-
Deep value in the remaining book. On the manager's estimates, MOV trades at ~2.7x prospective earnings at a 3% margin and BRI at ~10x hoped-for FY27 NPATA. With MOV now profitable and SND back in profit, the manager argues earnings recovery could re-rate an eight-stock book quickly. FY21 (+58.40%) shows the portfolio's upside convexity.
-
Corporate activity. CTL's ~19.9% blocking stake in BRI and the Greenstone strategic review create takeover or merger optionality at a core holding.
-
Cheap embedded tax shield and aligned insiders. Tax losses (DTA of $12.2m) shelter future gains. Directors and the CIO keep buying shares, and buybacks plus on-market DRP purchases prevent dilution. July 2026 already showed +3.83 percentage points of outperformance.
Bear case
-
The dividend is consuming capital. A 5 cps dividend on a 28c pre-tax NTA means a ~18% annual distribution. The profits reserve covers only ~1.6 years. Absent strong realised gains, NSC must cut the dividend, cut franking further, or keep returning capital, any of which could hit a share price now trading at a premium.
-
Leverage on a shrinking base. Notes of $13.24m equal ~36% of pre-tax NAV. Another -20% portfolio year would push gearing near 50% of NAV and could raise refinancing or covenant issues; the terms are not public.
-
Track record and scale. Performance is -8.92% p.a. relative to the benchmark since inception and -24.09% p.a. relative over three years. With ~$50m of assets, fixed costs above 3% of NAV and a premium that may not persist, a strategic outcome (merger with NCC or NAC, wind-up, or restructuring) becomes increasingly plausible. That would be a catalyst that could cut either way.
Key catalysts and monitorables (next 12 months)
| Timing | Monitorable |
|---|---|
| Monthly | NTA updates: pre-tax NTA trajectory versus the 28c base; premium/discount |
| ~Oct 2026 / Jan 2027 / Apr 2027 | Quarterly dividend declarations: rate (1.25 cps) and franking level |
| 12 Nov 2026 | AGM: director re-elections; any capital management or strategic commentary |
| End CY26 | SomnoMed Rest Assure go-to-market and FDA efficacy update |
| H1 FY27 | BRI strategic review outcome; CTL intentions |
| Feb 2027 | NSC H1 FY27 results; profits reserve balance; DTA treatment |
| Ongoing | Notes maturity and refinancing disclosure; buyback activity |
| Macro | RBA path; New Zealand recovery; residential construction cycle |
Analyst verdict
NSC is a small, leveraged, high-conviction LIC whose shareholder outcomes are driven by three things: a handful of illiquid industrial turnarounds, a generous dividend, and the market's swings between pessimism and optimism about NAOS. The underlying record is poor. Since NAOS took over in December 2017, the portfolio has lost a quarter of its value while the benchmark gained 60%. Five-year returns are double-digit negative per annum. Equity has fallen from $120m to $49m in four years.
Yet FY26 showed how disconnected the share price can be. Shareholders earned 33% while the portfolio lost 10%, because a 27% discount became a 16% premium. That premium is the crux of the current assessment. At ~1.14x pre-tax NTA, the market is paying above liquidation value for a vehicle with ~26% gearing on its portfolio, a profits reserve worth only about 1.6 years of dividends, declining franking, and a cost base that is heavy for its size. The premium likely reflects yield-seeking retail demand and confidence in the manager's FY27 recovery thesis. Some of that thesis has evidence: MOV is profitable, SND is profitable, and BRI has strategic optionality.
There are credible positives. Insiders keep buying and never sold. Capital management avoids dilution. The FY25 refinancing materially reduced interest burden. If two or three core holdings re-rate, an eight-stock leveraged book could recover NAV quickly. July 2026's outperformance is an early, though single-month, signal.
On balance, the risk/reward for a new investor is skewed unfavourably at a premium to NTA. The dividend is likely unsustainable at the current rate without portfolio gains, and the notes' terms and maturity are undisclosed in the sources reviewed. NSC is best viewed as a speculative recovery play on NAOS's stock-picking. Its key tests in FY27 are NAV growth, retention of the dividend, and clarity on refinancing and the vehicle's long-term scale. Monitoring, rather than conviction, is warranted.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed | Independence | Background and other roles | Education | FY26 total remuneration (AUD) | NSC shares at 30 Jun 2026 |
|---|---|---|---|---|---|---|---|
David Rickards OAM | Independent Chair (Chair since 10 Nov 2022) | 28 Feb 2018 | Independent | Ex-Macquarie executive director, global head of equities research and strategy (1989–2013); Barra International; co-founder of Sefa; former treasurer of Bush Heritage Australia; director of NAC | MBA (UQ); BE Civil and BE Structural (Sydney); BSc | 35,157 | 495,606 |
Sarah Williams | Independent Director | 25 Aug 2022 | Independent | Ex-Macquarie executive director and head of IT (asset management, investment banking, leasing); JP Morgan; PwC London; chair of NAC and NCC | Hons Engineering Physics (Loughborough) | 25,113 | 87,790 |
Trevor Carroll | Independent Director (Chair Oct 2017–Nov 2022) | 27 Mar 2017 | Independent | Ex-ANZ CEO of Electrolux Home Products; past director of The Good Guys, Fusion Retail Brands and Crane Group; Ai Group National President 2006–08 | BCom (Canterbury) | 25,113 | 229,089 |
Warwick Evans | Non-Independent Director | 20 Oct 2017 | Not independent (Chair of the Investment Manager) | Ex-MD of Macquarie Equities (1991–2001); founding Chair and CEO of the Newcastle Stock Exchange; Chair of the Australian Stockbrokers Association; County NatWest | BCom Economics (UNSW) | 25,113 | 961,212 |
Sebastian Evans | Non-Independent Director; joint Company Secretary | 20 Oct 2017 | Not independent (CIO and MD of NAOS) | CIO and MD of NAOS since 2010; director of NAC and NCC | MAppFin; BCom; GradDip Mgmt (AGSM); Dip Fin Services | Nil (paid by the Investment Manager) | 1,781,123 |
Executive Leadership Team
| Name | Role | Joined NAOS | Prior roles | Education |
|---|---|---|---|---|
Sebastian Evans | CIO and Managing Director | 2010 (CIO/MD) | — | As above |
Robert Miller | Portfolio Manager across all NAOS LICs | Sep 2009 (PM since Nov 2014) | — | BBus (UTS); MAppFin |
Jared Tilley | Senior Investment Analyst | Apr 2021 | Contact Asset Management; Colonial First State (9 years) | BCom (Notre Dame); CFA |
Tom Pearce | Associate Analyst | May 2025 | — | BCom/BAdvStudies (Sydney) |
Rajiv Sharma | Chief Business Officer; Company Secretary (since 12 Mar 2021) | 2017 | Magellan Financial Group; Custom Fleet (Element); Johnson Winter & Slattery; Clayton Utz | LLB (Hons I), BBus, GDLP (UTS) |
Mohit Kabra | Chief Financial Officer | 2025 | Deloitte, 17+ years across three continents | BCom (Hons) (Delhi); CPA (Colorado); AICPA; ICAI |
Angela Zammit | Marketing and Communications Manager | May 2020 | SAI Global; American Express; Citibank | BComms (Canberra) |
Governance Overview
| Item | Position |
|---|---|
Chair / CEO separation | NSC has no CEO. The Chair (Rickards) is independent of the Investment Manager. |
Board independence | 3 of 5 independent (60%) |
Committees | Not detailed in the retrieved filings; the Corporate Governance Statement is on naos.com.au/corporate-governance. |
Governance framework | Adopts the ASX Corporate Governance Principles and Recommendations [AR26] |
Key related-party arrangement | Investment management agreement with NAOS (1.15% management fee; 20% performance fee with high-water-mark-style recoupment). Two directors are affiliated with NAOS. |
Cross-directorships | All five NSC directors also sit on at least one other NAOS LIC board (NAC and/or NCC) |
Major Shareholders
| Holder | Shares | % of issued capital | Source / date |
|---|---|---|---|
Directors (aggregate) | 3,554,820 | ~2.69 | [AR26], 30 Jun 2026 |
NAOS Asset Management Ltd | 1,580,400 | 1.19 | [AGG – Motley Fool]; date not stated |
Directors and NAOS staff (aggregate) | ~3.2m | — | [AGM25], Nov 2025 (likely an earlier snapshot) |
Institutional ownership | Not publicly disclosed in retrieved sources. The register is predominantly retail; NAOS cites ~5,500 investors across its vehicles. | — | — |
Competitive Landscape
Key Competitors
| Competitor | Ticker | Category | Relative positioning vs NSC | Comparative data |
|---|---|---|---|---|
NAOS Emerging Opportunities | NCC | Sister LIC (smaller investees) | Same manager and board overlap; potential consolidation candidate | — |
NAOS Ex-50 Opportunities | NAC | Sister LIC (ex-ASX 50 industrials) | Same manager | Gross portfolio $47.5m (31 Jul 2026) [AGG – NAC NTA] |
WAM Microcap | WMI | Micro-cap LIC (Wilson Asset Management) | Much larger, diversified, strong brand | — |
Spheria Emerging Companies | SEC | Small/micro-cap LIC | Diversified value approach | — |
Ophir High Conviction | OPH | Small/mid-cap LIT | Growth-oriented | — |
Thorney Opportunities | TOP | Concentrated / activist small-cap LIC | Similarly concentrated and activist | — |
Glennon Small Companies | GC1 | Small-cap LIC | Similar size | — |
Sandon Capital Investments | SNC | Activist LIC | Engagement-led like NAOS | — |
Ryder Capital | RYD | Concentrated small/mid-cap LIC | High concentration | — |
ECP Emerging Growth (formerly Barrick Street) | ECP | Small/mid-cap LIC | Quality growth | — |
Small-cap ETFs (e.g., S&P/ASX Small Ords trackers) | Various | Passive | Low cost; benchmark-like returns | Benchmark +8.11% in FY26 |
Peer Comparison FY2026
| Metric | NSC | XSOAI benchmark | NAC |
|---|---|---|---|
FY26 return (%) | -9.86 | 8.11 | — |
3-year return p.a. to Jun 2026 (%) | -14.20 | 9.89 | — |
5-year return p.a. to Jun 2026 (%) | -11.18 | 2.98 | — |
Return p.a. since Dec 2017 inception (%) | -3.27 | 5.65 | — |
Gross portfolio, Jul 2026 (AUD Mn) | 50.6 | — | 47.5 |
Management fee (%) | 1.15 | — | — |
Recent Developments
--



